Related Experiment Video
Updated: Aug 15, 2026

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
Fungal infections in neutropenia: current problems and chemotherapeutic control
1Public Health Laboratory, Kingsdown, Bristol, UK.
Abstract:
Invasive fungal infection is a significant problem in neutropenic individuals. The commonest causes of infection are Aspergillus and Candida spp., although a growing number of other organisms (including species of Fusarium and Trichosporon) have been implicated. The clinical manifestations of these infections are described here, and diagnostic problems are discussed. The role of lipid-based formulations of amphotericin B, and of the triazole compounds, itraconazole and fluconazole, in the treatment and prevention of fungal infection is discussed.
Insights
Invasive fungal infections pose a serious threat to neutropenic patients, caused by fungi like Aspergillus and Candida. This review covers clinical signs, diagnosis, and treatment strategies, including antifungal medications.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Hematology
Background:
- Invasive fungal infections (IFIs) are a major cause of morbidity and mortality in neutropenic individuals.
- Common pathogens include Aspergillus and Candida species, with increasing reports of Fusarium and Trichosporon infections.
Purpose of the Study:
- To describe the clinical manifestations of IFIs in neutropenic patients.
- To discuss diagnostic challenges associated with these infections.
- To review current and emerging treatment and prevention strategies for IFIs.
Main Methods:
- Literature review of clinical manifestations, diagnostic approaches, and therapeutic options for IFIs in neutropenic populations.
- Analysis of the role of specific antifungal agents, including lipid formulations of amphotericin B and triazoles (itraconazole, fluconazole).
Main Results:
- IFIs present with diverse clinical symptoms, often posing diagnostic difficulties.
- Antifungal therapies, particularly lipid-based amphotericin B and triazoles, are crucial for management and prophylaxis.
Conclusions:
- Effective management of IFIs in neutropenic patients requires prompt diagnosis and appropriate antifungal therapy.
- Ongoing research into novel treatments and preventative measures is essential to combat the rising incidence of IFIs.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Fungal Phylum Microsporidia
Cryptococcal Meningitis
Candidiasis
Antifungal Agents
Antiprotozoal Agents

